Vestibular evoked myogenic potential (VEMP) testing hasgained popularity asa diagnostic modality in otolaryngology and audiology. To maximize the utility of this test, examiners need theavailability of ideal testsettings and reliable norms. We conducted a prospective study of 8 subjects with no history of neurotologic symptoms to examine the test-retest consistency of VEMP testing and to analyze the impact of stimulus type and muscle tension monitoring. All subjects underwent VEMP testing with two stimuli: a SOD-Hz tone and a click. With each stimulus, testing wascompleted with and without monitoring of sternocleidomastoid muscle tension. All subjects participated in an initial testing session and then returned for a repeat testing session 2 to 4 weeks later. We measured theamplitude ofprimarywaveforms P13 (first positive peak) and N23 (first negative peak) and analyzed the reliability and reproducibility of the mean amplitude asymmetry of these VEMP peaks. The P13 component of the VEMP (specificity: 86.25%) demonstrated a more stable amplitude than did the N23 component (specificity: 70.50%). Therefore, our statistical analysis of the effect of stimulus type and muscle tension monitoring on test-retest reliability was limitedto theP13 waveform. We found that neither the type of stimulus nor the presence or absence of muscle tension monitoring hadanystatistically significant effect on amplitudeasymmetry. We concluded that in VEMP testing, the P13 component was more specific than the N23 component in identifying normalsubjects and that theP13 componentprovided consistent results across test
Introduction
Vestibular evoked myogenic potential (VEMP) testing is a readily available and easily performed audiologic test used to assess saccular function and the integrity of the inferior vestibular nerve. Its use isbecoming more widespread in both otolaryngologyand audiology diagnostic practices. VEMP testing has been used in patients with cerebrovascular accidents, I acoustic neuromas,' vestibular neuritis,' herpes zoster oticus,' Meniere disease,' and superior semicircular canal dehiscence. ' In order to obtain the maximum benefit from VEMP testing, examiners need to know the ideal techniques for conducting testing and established ranges of normal results. Fewstudies have been conducted to evaluate the reproducibility ofVEMP results in normal subjects.' It is essential in the recording ofVEMPs to maximize the reliability of the amplitude of the primary waveforms P13 (first positive peak) and N23 (first negative peak). Also,the type ofstimulus that provides the most reliable VEMP waveform has not been determined. Moreover, there is some evidence that monitoring muscle tension can have an impact on the variability of these waveforms." Finally, some standard VEMP recording units are equipped with a built-in muscle tension monitor, but some authors prefer to use a conventional blood pressure cuff"
In this article, we describe our investigation to evaluate the specificity ofVEMP testing in normal subjects and to determine the impact that the type of stimulus and the presence or absence of sternocleidomastoid muscle control have on test reliability.
Subjects and methods
After we obtained Institutional Review Board approval for this investigation, we recruited study subjects from among patients who were being evaluated for nonoto-
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L ASL Pharmacy· Introduces the NasoNeb" ASLPharmacyl P> is nowdispensinga newdrug deliverydevice, which applies positive-pressure atomization to the sinuses." This device utilizes the latest irrigation and atomization technologies to provide dual-nostril, positive-pressure medication deposition in less than two minutes with minimal drug waste. This device allows for a broad range ofdrug combinations.
The Nasoxeb" is an FDA listeddrug deliverydevice, which applies a low-volume saline and medication atomization to both nostrils simultaneously, functioning like a power irrigator. After providing informed consent, the 8 volunteers were screened to confirm normal hearing. They were taken to a soundproof testing room, where thresholds for the octave frequencies from 500 to 4,000 Hz were established with acalibrated GSI61 audiometer (Grason-Stadler; Eden Prairie, Minn.) to confirm normal symmetrical hearing. Tympanometry was also performed. Exclusion criteria included evidence of middle ear disease, an asymmetry of 5 dB or greater, or an abnormal hearing sensitivity. All 8 subjects exhibited normal middle ear spaces and normal symmetrical hearing.
For additional information, please call and speak
We performed VEMP testing in all subjects and identified the primary waveforms (P13 and N23) and measured the amplitudes. The waveform amplitudes of the left and the right were used to calculate a mean amplitude asymmetry ratio (AAR).All subjects underwent testing (1) with two types of stimuli and (2) with and without sternocleidomastoid muscle contraction monitoring. Subjects were retested 2 to 4 weeks after their initial evaluation. The application of the testing conditions was performed in a randomized fashion at both the initial testing session and the retesting session. Subjects were asked to lie in a supine position on the testing table. VEMP testing was performed with the SmartEP system (Intelligent Hearing Systems; Miami). At the onset of testing, subjects were asked to elevate their head from the table and turn it at a 45°angle in the direction of the stimulus. Two separate recordings were made at a lO-minute interval, one with a 500-Hz tone and one with a click stimulus, both at 100 dB nHL. Each test was captured by traditional electrode montage and recording techniques with the recording electrodes placed on the sternocleidomastoid muscle ipsilateral to the ear being tested and at the high forehead with a ground electrode on the midforehead. Recordings were made of the latency and amplitude of P13 and N23; no effort was made to record the N34 and P44 peaks.
The use of a muscle tension monitor was another variable in this study. Sternocleidomastoid muscle contraction was encouraged in all subjects. Constant contraction was initiated by instructing subjects on proper contraction and then maintained by either coaching and observation by the test administrator or by allowing the subjects to monitor their own muscle 172 • www.entjournal.com contraction with a hand-held monitor.
Subjects were asked to return to the clinic 2 to 4 weeks following the initial test session for a repeat test to determine the reliability ofthe initial results. Administration of the repeat test was identical to that of the initial test except that the screening pure-tone audiometry was not performed.
Results were quantified in terms of AAR,7 which is calculated according to this equation:
There is no absolute standard that determines the clinical significance of any particular AAR,but a range from 30 to 47% is commonly used.' Individual institutions have been advised to determine their own normative values. Our institution has designated an AAR of 34% or higher as abnormal, and that is the threshold we used in this study.
Our statistical analysis took into consideration the specificwaveform, the type of stimulus, and the presence or absence ofmuscle monitoring at each testing session. Group means for AARand for VEMP specificity at each testing session were obtained.
Results
VEMP test results were easily obtained in all subjects.
Amplitude asymmetry ratios. Analysis of variance (ANOVA) revealed that the mean AAR for P13 was significantly lower (p < 0.001) than the mean AAR for Specificity. The overall specificity of the P13 mean AAR was 86.25%, and that of the N23 mean AAR was 70.50% (figure 2).
Discussion
The usefulness of a diagnostic test is dependent on its specificity and sensitivity. By manipulating a test set- ting, one can develop a highly sensitive test in which all patients, regardless of their true status, will yield an abnormal result. Conversely, with stringent settings, tests can be made highly specific so that results in all patients will be normal, regardless of the presence or absence of pathology. Ideally, any new test should be first evaluated in a normal patient population that has no known pathology. This allows examiners to identify conditions and variables that are consistent with normal findings, to establish quantifiable ranges of normative values, and to develop appropriate testing conditions. Obviously, we would expect that any reliable diagnostic test would have a high specificity in a group of normal subjects.
The purpose of our study was to determine the reliability and specificity of VEMP vis a vis 4 variables:
primary waveform (P13 and N23), type of stimulus (SOO-Hz tone and click), sternocleidomastoid muscle contraction monitoring (with and without), and the timing of the testing session (initial test and retest). We found that the mean AAR of the P13 waveform was statistically superior to that of the N23 component and that this superioritywas consistent regardless ofthe type of stimulus used, the status of muscle monitoring, and the timing of the test.
Type ofstimulus.Atrend has emerged in the literature 174 • www.entjournal.com in favor of a tone burst rather than a click stimulus in eliciting VEMP responses. Wu et al reported that the tone burst had an advantage over the click in terms of the latency and amplitude of each waveform, although they found no difference in AAR. 8 Weigampola and Colebatch reported that a tone burst stimulus of 500 or 1,000 Hz elicited the greatest amplitude of both waveforms." Our study found that the type of stimulus had no significant effect on the AAR for P13.
Muscle monitoring. The consensus in the literature is that sternocleidomastoid muscle stimulation has a positive impact on VEMP amplitude stability. For example, Colebatch et al demonstrated a linear relationship between sternocleidomastoid electro myographic activity and VEMP waveform amplitude. 10 However, the issue of whether monitoring of muscle stimulation makes any difference in VEMP testing results has yet to be settled. Vanspauwen et al found that waveform amplitude variability decreased when they used a blood pressure cuff to monitor muscle contraction."
During our study, we used a handheld light box that provided immediate feedback to subjects regarding the quality of their muscle contraction. We found that muscle tension monitoring provided no statistically significant advantage; this finding should be confirmed in a larger study group. Omitting muscle RADIESSE® Voice and RADIESSE® Voice Gel Implants for vocal fold augmentation !00IESSE" Voice BioForm Medical, Inc. I www.radiesse-voice.comlent@bioformmedical.comINorth America: 1-866-862-1211 I Europe: +31-0-162-474-800
In clinical testing and routine clinical use for over 6 years, no implant migration or evidence of granuloma formation has been observed.
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Over time the RADIESSE Voice implant carrier gel is resorbed and the Calcium Hydroxylapatite particles support in-growth of new collagen . The durable Calcium Hydroxylapatite microspheres degrade slowly over years for a long-lasting effect. The implant remains soft after injection and does not ossify.
Thyrohyoid injection technique
No fat harvesting or processing No preparation or mixing -supplied in ready-to-use 1.0 cc syringe with injection needle No refrigeration -store at room temperature No allergy testing -contains no animal or human components No waiting -injection can be performed in-office in 30 minutes or less
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Convenient and easy-to-use
Macrophages startto degrade gelcarrier (2) (3) The RADIESSE Voice Gel injectable implant contains synthetically derived polymers, with no CalIA microspheres. and it is su itable for short term vocal fold augmentation in patients where reversible nerve damage is suspected, or in patients wishing a short term augmentation before deciding to have a long term augmentation done with the RADIESSE Voice implant.
RADIESSE Voice Products
The RADIESSE Voice injectable implant contains synthetic Calcium Hydroxylapatite (CalIA) microspheres, which have a diameter of 25-45 micron, suspended in an aqueous resorbable carrier gel. The product is injectable through a 25-gauge needle. RADIESSE Voice implant provides vocal fold augmentation with results that typically lasts 1 year. tension monitoring from future testing protocols might simplify testing somewhat and decrease its cost, although our monitoring equipment is easy to use. The key to satisfactory muscle monitoring is to instruct patients on proper head elevation and to provide them with verbal feedback to discourage fatigue during testing. Testing patients with cervical problems, those who are uncooperative, and those who may not be physically able to maintain muscle contraction can be a challenge. Wang and Young suggested the use of effortless head rotation as an alternative to head elevation, but this technique may result in a lower waveform amplitude."
In conclusion, VEMP testing is a readily available and easily performed audiologic test. Based on our results, VEMP responses are consistently reproducible, and P13 amplitude asymmetry is significantly lower than N23 asymmetry among normal subjects.VEMP testing based on a P13 analysis is more specific than that based on N23 in terms of correctly identifying normal subjects, and it provides consistent results across test sessions regardless of the type of stimulus and the presence or absence of muscle tension monitoring. VEMP testing is in wide clinical application, and our study provides additional information on its precision.
